Anaplan Has The Ingredients For 'The Next Execution Story In Software,' Says Bullish Rosenblatt
The cloud-based planning software provider Anaplan Inc's (NYSE: PLAN) near-term as well as long-term growth prospects are encouraging, according to Rosenblatt Securities.
The Analyst
Yun Kim has a Buy rating on Anaplan with a $71 price target.
Anaplan's 'Enterprise-Ready' Sales Organization
Anaplan is seeing strong business momentum, Kim said in a Friday note, citing Rosenblatt's recent checks with global system integrators, or GSIs. (See his track record here.)
The GSIs are increasing their investments into their Anaplan practices and intend to increase the number of trained Anaplan consultants meaningfully for next year, the analyst said.
"We believe GSIs' continued investment into their PLAN practice reflects the increasingly strategic nature of their partnership with PLAN."
Large GSIs are actively selling Anaplan's highly quantifiable ROI solution along with large digital transformation projects, Kim said.
Much of the incremental traction with GSIs will likely lead to accelerated billings growth next year, especially in the Americas, the analyst said.
With the recent hiring of Mark Anderson, a respectable sales executive in the industry, Anaplan is building one of the "best enterprise-ready" sales organization in the industry, according to Rosenblatt.
Anaplan's "connected planning" solution is quickly becoming the next killer app in the software industry, as evidenced by a 40% billings growth rate that continues to accelerate and the $250,000-plus in annual recurring revenue generated by 25% of its customers, Kim said.
"We believe PLAN has all the right ingredients to be the next execution story in software."
Anaplan Price Action
Anaplan shares have nearly doubled year-to-date. The stock was trading down 0.8% at $52.21 at the time of publication.
Related Links:
10 Software Top Picks For 2020: Do You Own Them?
Wall Street Likes Coupa Software After Revenue, Sales Beats
Latest Ratings for PLAN
Date | Firm | Action | From | To |
---|---|---|---|---|
Mar 2022 | Mizuho | Maintains | Buy | |
Mar 2022 | Morgan Stanley | Maintains | Equal-Weight | |
Mar 2022 | Wells Fargo | Maintains | Overweight |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Rosenblatt Securities Yun KimAnalyst Color Price Target Reiteration Analyst Ratings Trading Ideas Best of Benzinga